The Protective Effect of HDL-Cholesterol in Patients with Essential Hypertension

Balint, Germaine Savoiu; Iovănescu, Gheorghe; Stanca, Horia Tudor; Popoiu, Călin Marius; Boia, Eugen Sorin; Popovici, Ramona Amina; Bolintineanu, Sorin

doi:10.37358/rc.17.5.5587

Cited by 7 publications

(4 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The relationship between hypercalcemia and mortality has been demonstrated in a number of studies ( 88 , 89 ). Hypercalcemia increases mortality through predisposition to arrhythmia, high BP ( 90 ) and VC.…”

Section: Calcium (Ca 2+ )mentioning

confidence: 98%

“…Hypocalcemia occurs in the dialysis patients because of the use of calcimetics, non-calcium phosphates binders and low level Ca 2+ dialysate, as well as dietary Ca 2+ intake ( 23 , 89 , 92 ).…”

Section: Calcium (Ca 2+ )mentioning

confidence: 99%

“…Ca concentration in the dialysate has both short-term and long-term effects. Increased calcium in the dialysate (1.75 mmol/l) influences PTH control and hemodynamic instability, but contributes to accelerated VC and bone and mineral imbalance, with adynamic bone ( 89 ).…”

Section: Calcium (Ca 2+ )mentioning

confidence: 99%

See 2 more Smart Citations

Dyselectrolytemia‑management and implications in hemodialysis (Review)

et al. 2020

View full text Add to dashboard Cite

Hemodialysis is a method for the renal replacement therapy followed by series of acute and chronic complications. Dyselectrolytemia appears in patients undergoing dialysis through mechanisms related to the chronic kidney disease and/or to the dialysis therapy and for this group of patients it is associated with an increase of morbidity and mortality. The dialysate has a standard composition, which can be modified according to the patient's characteristics. During hemodialysis patients are exposed to 18,000-36.000 litres of water/year, and the water purity along with the biochemical composition of the dialysate are essential. The individualization of the dialysis prescription is recommended for each patient and it has an important role in preventing the occurrence of dyselectrolyemia. The individualization of the treatment prescription according to the blood constants of each patient is the prerogative of the nephrologist and the association of the electrolyte imbalances with the patients cardiovascular mortality explains the importance of paying special attention to them.

show abstract

Section: Calcium (Ca 2+ )mentioning

confidence: 98%

Section: Calcium (Ca 2+ )mentioning

confidence: 99%

See 1 more Smart Citation

Dyselectrolytemia‑management and implications in hemodialysis (Review)

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The increase in the number of hypertensive and diabetic patients globally leads to an increase in the prevalence of CKD. Over time, high blood pressure and diabetes can lead to kidney damage (1)(2)(3). High blood pressure may occur as a consequence of CKD induced by another pathology (4).…”

Section: Introductionmentioning

confidence: 99%

Abdominal aortic calcification in predialysis patients: Contribution of traditional and uremia‑related risk factors

et al. 2020

View full text Add to dashboard Cite

Cardiovascular disease is the main cause of morbidity and mortality in end-stage renal disease (ESRD) patients. Recent population based epidemiological studies demonstrated a correlation between reduced renal function and risk for all causes and cardiovascular mortality, 50% of patients dying before the commencement of renal replacement therapy. Vascular calcifications (VC) and arterial stiffness are major contributors to cardiovascular disease and are independent predictors of cardiovascular mortality in ESRD patients. Scarce information is available on the risk factors and prognosis of predialysis patients with VC. The aim of this study was to evaluate the contribution of traditional and uremia related risk factors to abdominal aortic calcification in predialysis patients. A single center, retrospective study was performed on 305 adult patients monitored at the Bucharest University Emergency Hospital for at least 6 months. Our study reports an increased incidence of VC in predialysis chronic kidney disease (CKD) patients, higher in those with advanced age, history of cardiovascular disease, osteoporosis, and declining renal function.

show abstract